RUSSO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 17.153
AS - Asia 8.156
NA - Nord America 6.295
SA - Sud America 1.381
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 33.094
Nazione #
RU - Federazione Russa 12.634
US - Stati Uniti d'America 6.148
SG - Singapore 2.939
CN - Cina 1.694
IE - Irlanda 1.586
HK - Hong Kong 1.398
BR - Brasile 1.158
VN - Vietnam 1.045
IT - Italia 603
GB - Regno Unito 528
DE - Germania 510
FR - Francia 407
KR - Corea 348
UA - Ucraina 252
IN - India 233
SE - Svezia 149
GR - Grecia 122
AR - Argentina 101
FI - Finlandia 98
JP - Giappone 77
TR - Turchia 69
AT - Austria 66
CA - Canada 57
MX - Messico 53
BD - Bangladesh 48
ID - Indonesia 44
NL - Olanda 43
AE - Emirati Arabi Uniti 38
EC - Ecuador 38
PL - Polonia 36
IQ - Iraq 34
CZ - Repubblica Ceca 26
BE - Belgio 24
SA - Arabia Saudita 23
ZA - Sudafrica 23
TH - Thailandia 22
PK - Pakistan 21
PY - Paraguay 20
UZ - Uzbekistan 18
MA - Marocco 16
CO - Colombia 15
EG - Egitto 14
ES - Italia 14
VE - Venezuela 14
JO - Giordania 13
PH - Filippine 12
CL - Cile 10
PE - Perù 10
DO - Repubblica Dominicana 8
IL - Israele 8
LB - Libano 8
LT - Lituania 8
UY - Uruguay 8
AL - Albania 7
MY - Malesia 7
NP - Nepal 7
OM - Oman 7
TN - Tunisia 7
BO - Bolivia 6
CH - Svizzera 6
ET - Etiopia 6
HN - Honduras 6
JM - Giamaica 6
KE - Kenya 6
RO - Romania 6
SN - Senegal 6
DZ - Algeria 5
PT - Portogallo 5
QA - Qatar 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
IR - Iran 4
NI - Nicaragua 4
PA - Panama 4
PS - Palestinian Territory 4
AM - Armenia 3
BH - Bahrain 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
RS - Serbia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UG - Uganda 2
Totale 33.076
Città #
Moscow 4.557
Dublin 1.583
Hong Kong 1.377
Singapore 1.277
Santa Clara 1.126
San Jose 709
Chandler 506
Jacksonville 461
Hefei 381
Ashburn 376
Seoul 344
Ho Chi Minh City 334
Hanoi 244
Princeton 228
The Dalles 209
Dallas 207
Roxbury 190
Beijing 166
Bengaluru 157
Bremen 130
Medford 123
Cambridge 114
São Paulo 96
Munich 91
Naples 87
Da Nang 81
Ann Arbor 74
Wilmington 70
Boardman 69
Nuremberg 64
Los Angeles 63
New York 60
Des Moines 52
San Mateo 48
Haiphong 47
Falkenstein 38
Council Bluffs 37
Caserta 36
Belo Horizonte 35
Woodbridge 34
Orem 33
Vienna 29
Atlanta 27
Rio de Janeiro 27
Warsaw 27
Guangzhou 26
Jinan 26
Rome 25
Brussels 24
Mexico City 24
Changsha 23
Amsterdam 22
London 22
Tokyo 22
Frankfurt am Main 21
Tianjin 21
Aversa 20
Brno 20
Chennai 19
Manchester 19
Bắc Ninh 18
Guarulhos 18
Shenyang 18
Stockholm 18
Brooklyn 17
Hải Dương 17
Lappeenranta 17
Turku 17
Zhengzhou 17
Chicago 16
Curitiba 16
Shanghai 16
Tashkent 16
Columbus 15
Houston 15
Porto Alegre 15
San Francisco 15
Hangzhou 14
Helsinki 14
Lusciano 14
Milan 14
Nanchang 14
Nanjing 14
Yan Ta Khao 14
Biên Hòa 13
Amman 12
Boston 12
Brasília 12
Dhaka 12
Düsseldorf 12
Ercolano 12
Guayaquil 12
Montreal 12
Mumbai 12
Norwalk 12
Quito 12
Salvador 12
Toronto 12
Afragola 11
Can Tho 11
Totale 16.928
Nome #
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 165
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 164
Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. 158
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 156
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 150
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 150
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 150
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 147
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 146
Acute myocarditis: prognostic role of speckle tracking echocardiography and comparison with cardiac magnetic resonance features 146
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 145
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 144
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 144
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 144
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 143
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 140
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 139
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 139
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 137
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 137
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 136
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 135
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 135
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 135
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 134
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 134
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients 134
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders 134
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 133
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 133
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 133
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 133
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 132
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 131
Coronary sinus spasm during left ventricular lead implantation for biventricular pacing 131
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 130
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 129
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 128
A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality 128
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 127
Sympathovagal balance analysis in idiopathic postural orthostatic tachycardia syndrome. 126
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 126
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 125
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 125
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 124
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study 124
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 123
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 123
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 123
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management 122
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 122
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 122
Myocardial Work Efficiency in Physiologic Left Ventricular Hypertrophy of Power Athletes 120
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 120
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 119
Air entrapment as a cause of S-ICD inappropriate shocks 118
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 117
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 117
Effects of High Intensity Interval Training Rehabilitation Protocol after an Acute Coronary Syndrome on Myocardial Work and Atrial Strain 117
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 116
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation 116
Biventricular pacing and heterogeneity of ventricular repolarization in heart failure patients 116
Superior vena cava thrombosis after intravascular AICD lead extraction: a case report 115
Anti-arrhythmic properties of non-antiarrhythmic medications 115
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 115
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 114
COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden 114
Vasovagal Syncope at Work: A Narrative Review for an Occupational Management Proposal 114
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 114
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 114
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis 114
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 113
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 113
Echocardiography in Cardiac Arrest: Incremental Diagnostic and Prognostic Role during Resuscitation Care 112
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 112
Giant coronary sinus in patient with double superior vena cava demonstrated by multislice computed tomography 112
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 112
Put out the fire: The pleiotropic anti-inflammatory action of non-vitamin K oral anticoagulants 111
TAKOTSUBO CARDIOMYOPATHY AS EPIPHENOMENON OF CARDIOTOXICITY IN CANCER PATIENTS: A META SUMMARY OF CASE REPORTS 111
Smartphone and new tools for Atrial Fibrillation diagnosis: evidence for clinical applicability 111
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 110
Advances in Nanomedicine for Precision Insulin Delivery 109
Echocardiography in the Ventilated Patient: What the Clinician Has to Know 109
The role of multimodality imaging in athlete’s heart diagnosis: Current status and future directions 109
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 109
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 108
Relationship Between Left Atrial Strain and Atrial Fibrillation: The Role of Stress Echocardiography 108
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 108
Takotsubo Syndrome and Oxidative Stress: Physiopathological Linkage and Future Perspectives 107
Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. 107
111Ag phantom images with Cerenkov Luminescence Imaging and digital autoradiography within the ISOLPHARM project 106
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 106
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 105
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network 104
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 103
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 103
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 103
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 102
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 102
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 102
Totale 12.406
Categoria #
all - tutte 109.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021266 0 0 0 0 0 0 0 0 0 72 166 28
2021/20221.401 51 18 34 46 395 4 8 33 39 145 199 429
2022/20232.500 256 29 38 180 235 172 9 110 1.374 28 37 32
2023/20241.110 70 39 50 64 448 51 44 19 11 29 78 207
2024/20255.241 30 46 19 68 752 664 447 447 757 1.086 452 473
2025/202621.267 915 1.133 1.331 1.212 1.705 11.710 1.264 814 883 300 0 0
Totale 33.678